Ovid Therapeutics
OVID | NASDAQ
$2.40
-$0.14 (-5.51%)
At close: Nov 16, 2026, 4:00 PM ET
$2.44
+$0.04 (+1.60%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-5.51%
(1D)No price chart data available for 1D timeframe.
Rating
52.5
Fundamentals Average
Market Sentiment Bullish
Moat None
Sector Rank #229/1021 (Top 22%)
Key Statistics
Market Data
Market Cap $487.25M
1D Range
2.38 2.66
52W Range
1.22 2.96
Valuation (TTM)
PE -5.85
PB 2.45
EV/EBITDA -8.26
Valuation (NTM)
Forward PE N/A
Forward PEG 0.38
Price Target $6.00
Cash Flow
FCF Yield -11.9%
SBC Adj. FCF Yield -12.7%
SBC Impact -6.8%
Margins
Gross Margin 100.0%
Operating Margin -4700.3%
FCF Margin -3981.9%
Growth (CAGR)
Revenue 3Y | 5Y 69.8% |
-63.2%
Dil EPS 3Y | 5Y 6.5% |
21.6%
FCF 3Y | 5Y 0.1% |
1.7%
Returns
ROA -19.4%
ROE -23.4%
ROIC -32.2%
Financial Health
Net Cash
$136.6M
Current Ratio 11.97
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Ovid Therapeutics Inc. is a biopharmaceutical firm dedicated to creating significant treatments for individuals and families impacted by neurological disorders across the United States. The company's ...
Sector Healthcare
Industry Biotechnology
Employees 23
IPO Date May 5, 2017
Website www.ovidrx.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
4
Consensus
Buy
Price Target
$6.00
Upside
+150.00%
Buy (4)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove OVID